K-State infectious disease scientist offers road map for future COVID-19 research

May 14, 2020

MANHATTAN, KANSAS -- There are many unanswered questions about COVID-19. A Kansas State University infectious disease scientist and collaborators are offering a possible research road map to find the answers.

Vector-Borne and Zoonotic Diseases. Co-authors include Tracey McNamara from Western University of Health Sciences and Larry Glickman from Purdue University.

"We need to address these challenges in a scientific manner -- in a proactive manner, not in a reactive manner," said Richt, also the director of the university's Center of Excellence for Emerging and Zoonotic Animal Diseases, known as CEEZAD. "With COVID, every day something is new -- what was correct yesterday, could be wrong today."

Because of the rapid change of knowledge related to coronavirus, Richt and his collaborators wrote the article to stress importance of studying the ways that COVID-19 could spread between humans and animals. The scientists say that research should focus in several areas, including:
  • The potential for companion animals, such as cats and dogs, to carry the virus.

  • The economic and food security effects if the virus can spread among livestock and poultry.

  • National security areas, especially among service animals such as dogs that detect narcotics or explosives because COVID-19 is known to affect smell and cause hyposmia or anosmia.

"If dogs are susceptible and lose their smell and taste, it could affect our national security," said Richt, who also serves on an expert panel for the World Health Organization. "If livestock are also susceptible, it could significantly affect food safety and food security, too."

Richt's recent research has shown that pigs do not seem to be susceptible to coronavirus, but little is known if the virus affects cattle, sheep, chickens or wildlife. He is further studying if other livestock, such as cattle or sheep, may be susceptible to coronavirus.

The K-State

"Time is of the essence when responding to a new biological threat, and everyone at the BRI greatly appreciates the continued support from K-State leadership who realized the importance of keeping us operational," said
Stephen Higgs, director of the BRI and editor-in-chief of Vector-Borne and Zoonotic Diseases. "Thanks to our dedicated and highly skilled BRI staff, we provided the safe, secure environment, training and infrastructure required for research on SARS-CoV-2. The paper explains why Dr. Richt's research in the BRI is so important to all of us and it was great that we were able to publish it so quickly and make it freely available."

Richt's own coronavirus research at the Biosecurity Research Institute focuses on four areas: animal susceptibility and transmission of SARS-CoV-2, therapeutic treatments, diagnostics and vaccines. Richt develops models to test therapies and has collaborated with researchers nationally and internationally. He also is collaborating to test and develop potential vaccines that are safer and do not lead to vaccine-associated enhancement of the disease, which is an important issue for coronavirus vaccines.

One of his collaborative projects involves Sean Joseph with Scripps Research, Sumit Chanda with Sanford Burnham Prebys Medical Discovery Institute and Adolfo García-Sastre with Icahn School of Medicine at Mount Sinai. The project has involved repurposing existing drugs that have been approved by the Food and Drug Administration for treating cancer, leprosy, Crohn's disease and other illnesses.

The researchers used a National Institutes of Health library of 12,000 drugs and tested them against COVID-19 in cell cultures to see if they inhibit SARS-CoV-2 replication. They have narrowed the list of drugs down to about 20 potentially effective drugs. Richt is now testing these potential antiviral drugs in preclinical models.

Another collaborative project with Nevan Krogan with University of California San Francisco and Adolfo García-Sastre with Icahn School of Medicine at Mount Sinai focuses on repurposing drugs based on coronavirus protein--host protein interaction studies.

"We are on the front end of studying whether these drugs, which look very promising in cell culture assays, can be used in COVID patients," Richt said. "We hope that the work we are doing presently will save lives."
-end-


Kansas State University

Related Answers Articles from Brightsurf:

Children don't know how to get proper nutrition information online
Children looking for health information online could end up more prone to obesity.

Improved neural probe can pose precise questions without losing parts of the answers
A technique for studying individual circuits in the brains of mice has been hampered because the light needed to stimulate neural activity briefly overwhelms the electrodes 'listening' for the response.

Hate speech dominates social media platform when users want answers on terrorism
People often resort to using hate speech when searching about terrorism on a community social media platform, a study has found.

What is your risk from smoking? Your network knows!
A new study from researchers at Penn's Annenberg School for Communication found that most people, smokers and non-smokers alike, were nowhere near accurate in their answers to questions about smoking's health effects.

Major epilepsy study offers much-needed answers on 3 lifesaving seizure drugs
There are effective treatments to stop life-threatening epilepsy seizures when the initial treatment has failed, a sweeping new study reveals.

What leads to compulsive alcohol use? New experiments into binge drinking provide answers
New study from neuroscientists at Vanderbilt provides initial answers to long-standing scientific questions on what causes the transition from moderate to compulsive alcohol consumption - and what makes some drinkers particularly vulnerable to developing alcohol use disorders.

A further step towards reliable quantum computation
A team of physicists from the University of Vienna and the Austrian Academy of Sciences introduces a novel technique to detect entanglement even in large-scale quantum systems with unprecedented efficiency.

Civility still matters to some in cyberspace
In the online world, where incivility is all too common, new research from the McCombs School of Business at The University of Texas at Austin found that being polite is golden, at least when individuals who pose questions online get to choose the ''best answer.''

New software tool could provide answers to some of life's most intriguing questions
A University of Waterloo researcher has spearheaded the development of a software tool that can provide conclusive answers to some of the world's most fascinating questions.

Genetic testing gives answers on developmental disorders during pregnancy
Genetic testing improves diagnoses of abnormalities in developing babies picked up during ultrasound scans, scientists report today in The Lancet.

Read More: Answers News and Answers Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.